
	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands, except share and per share amounts)	2025		2024		2025		2024
Numerator:



Net loss attributable to common stockholders	$	(52,591)	$	(55,327)	$	(104,481)	$	(101,088)
Denominator:
Weighted-average common shares outstanding, basic and diluted	129,185,918		119,188,866		128,439,349		111,827,522
Net loss per share attributable to common stockholders, basic and diluted	$	(0.41)	$	(0.46)	$	(0.81)	$	(0.90)

Diluted net loss per share available to common stockholders is computed by giving effect to all potentially dilutive common stock equivalents outstanding for the period. For purposes of this calculation, preferred stock, unvested restricted stock and stock options to purchase common stock were considered common stock equivalents but had been excluded from the calculation of diluted net loss per share available to common stockholders as their effect was anti-dilutive. In periods in which the Company reports a net loss available to common stockholders, diluted net loss per share available to common stockholders is the same as basic net loss per share available to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.

The following common stock equivalents were excluded from the calculation of diluted net loss per share applicable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	As of June 30,
	2025	2024
Anti-dilutive common stock equivalents:
Options to purchase common stock	17,685,319	12,007,443
Unvested restricted common stock	3,472,546	3,729,877
Total anti-dilutive common stock equivalents:	21,157,865	15,737,320